Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
BANGKOK, Thailand, March 22, 2018 -- Amlan International, a leader in the supply of innovative solutions to improve intestinal health and productivity for livestock, announces that Dr. Hyun Soon Lillehoj, a senior research immunologist at the United States Department of Agriculture (USDA), will present on alternatives to in-feed antibiotics at the Asia Pacific Poultry Conference (APPC) in Bangkok, being held March 25–27, 2018.
Dr. Lillehoj is recognized worldwide as a leading authority on the research and development of antibiotic alternatives for the prevention and treatment of poultry diseases. She is the recipient of numerous awards for excellence in research in poultry diseases and health that span her entire career. She will make her presentation, titled “Immune Modulation of Host Response to Coccidiosis and Necrotic Enteritis to Reduce Antibiotics,” on Tuesday, March 27, 2018, in the Crystal A Room, The Athenee Hotel, Bangkok.
“Restrictions on the use of antibiotic growth promoters remain one of the biggest challenges for poultry producers,” says Ron Cravens, president, Amlan International, a Nevada corporation. “We’re delighted to bring Dr. Lillehoj’s expertise to the APPC and, along with our depth of experience in innovative intestinal health additives, provide a productive dialogue on viable approaches to protecting animals from biotoxic challenges to enhance livestock health and performance.”
For more information about Amlan’s portfolio of intestinal health products, visit Amlan.com. Note to media: For an interview with Dr. Lillehoj, please contact Reagan Culbertson at 312.706.3256 (United States), or [email protected].
About Amlan International
Oil-Dri Corporation of America (NYSE:ODC), a Delaware corporation doing business as “Amlan International,” has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted at its laboratory campus in Vernon Hills, Illinois. In 2017, the company added the Richard M. Jaffee Laboratory for Applied Microbiology to the campus.
Amlan International sells animal health products outside of the United States, and product availability may vary by country. Product-associated claims do not constitute medical claims and may differ based on government requirements. The information contained herein is based on Amlan’s research and you should conduct your own tests to determine the suitability of Amlan’s products for your specific purposes. “Amlan,” “Varium” and “NeoPrime” are trademarks of Oil-Dri Corporation of America.
Reagan B. Culbertson
Media Contact
[email protected]
